¹B°Ê¥Í²z¾Çºô¯¸ ·|­û¡G¥¼µn¿ý¡@µn¤J¡@§Ñ°O±K½X¡@¥Ó½Ð¥[¤J·|­û ¡@·|­û9724 ¡@³¡¸¨®æ5¡@¡@


¹B°Ê¥Í²z¶g°T ¹B°Ê¥Í²z¶g°T(³Ì·s¦^À³) ¦^¶g°T­º­¶

¹B°Ê¥Í²z¶g°T¹B°Ê¥Í²z¶g°T¹q¤l³ø
Online ISSN : 1814-7712
ª©Åv©Ò¦³ ¥¼¸g¦P·N ½Ð¤ÅÂà¸ü©Î¸`¿ý

¹B°Ê±`ÃÑ °V½m·§½× ¯à¶q¨Ó·½ ©I§l´`Àô ¦Ù¦×°©Àf ¹B°ÊÅé¯à °V½m¤èªk
¨­Åé²Õ¦¨ ¹B°ÊÀç¾i ¹B°ÊÀô¹Ò ¹B°Ê¶Ë®` ¬ã¨s¤èªk ºô¯¸µo®i ¬ÛÃö°T®§

¥DÃD¡G²Ä¤GÃþ«¬¿}§¿¯f¨­Å鬡°Ê»P¹B°Ê«ü¾É·s«äºû
µo¨¥ : ¤è¶i¶© ®É¶¡ : 22/05/30(11:45:40) From : 1.175.169.22 ¤ÀÃþ : ¹B°Ê±`ÃÑ
¹B°Ê¥Í²z¶g°T(²Ä490´Á)

²Ä¤GÃþ«¬¿}§¿¯f¨­Å鬡°Ê»P¹B°Ê«ü¾É·s«äºû(May 30, 2022)

¥xÆW®v¤j¦WÅA±Ð±Â ¤è¶i¶©

³ü¡B«e¨¥

¡@¡@¹B°ÊÂå¾Ç©Î¹B°Ê¬ì¾Ç¬ã¨s¤é·s¤ë²§¡A³Ìªñ°ê¤º¥~³°Äòµoªí¹B°Ê»P¿}§¿¯fªº¬ÛÃö¤åÄm¡A¦p2022¦~¡u¹B°Ê/¨­Å鬡°Ê»P²Ä¤GÃþ«¬¿}§¿¯f¦@Ãѳø§i¡v(Kanaley, et.al., 2022) µ¥¡A¥H¸É¥R2010¦~¬ü°ê¹B°ÊÂå¾Ç·| (ACSM, American College of Sports Medicine) ©M¬ü°ê¿}§¿¯f¨ó·|¦@¦Pµoªíªº¤åÄm (Colberg, et al., 2010( ¬ÛÃö¤º®e¡A»á­È±o°Ñ¦Ò¡C

¡@¡@¿}§¿¯f¬O¦å¿}¥NÁ²§±`ªº¯e¯f¡A¥D­n­ì¦]¬O¯Ø®q¯À¤Àªc²§±`©Î¬O¥\¯à»Ùê©Ò¤Þ°_ªº°ª¦å¿}¯gª¬¡C ªø´Á¦å¿}¹L°ª·|¤Þ°_³\¦h°·±d°ÝÃD¡A¥]¬A¤p¦åºÞ¯fÅÜ (¦pµøºô½¤©ÎµÇµ·²y¯fÅÜ)¡B¤j¦åºÞ¯e¯f (¦p«aª¬°Ê¯ß©Î¶gÃä¦åºÞ¯e¯f) ©M¯«¸g¯fÅÜ (¦p©PÃ䯫¸g©M¦Û¥D¯«¸g¯fÅÜ)¡A¤]¼W¥[¤ß¦åºÞ¯e¯f¦MÀI¦]¤l (ACSM, 2022)¡A¦]¦¹¡Aºû«ù¦å¿}í©w¬O±±¨î¿}§¿¯fªº­«­n¥Ø¼Ð¡C

¡@¡@¥Ø«e¿}§¿¯fªº¿©±w²v¬ù10%¡A¥D­n¤À¬°²Ä¤@Ãþ«¬ (T1D) ¥e5-10%¡A©M²Ä¤GÃþ«¬¿}§¿¯f (T2D) ¥e90-95%¡C§ïµ½¿}§¿¯fªº¥D­n¤èªk¬°ÃĪ« (¯Ø®q¯À)¡B¶¼­¹©M¹B°Ê¡A¦]¦¹¡A­n¦³®Ä©M¦w¥þ§ïµ½¿}§¿¯f¡A°£¨ÌÂå¥Í«ØÄ³ªAÃÄ¥~¡A¤]­n¾i¦¨°·±d¥Í¬¡¤è¦¡¡A¥]¬A¨}¦n¶¼­¹»P³W«ß¹B°Ê¡A¨Ã¤F¸Ñ³o¤TºØ¤èªk¹ï¦å¿}ªº¥æ¤¬§@¥Î (glucose interaction)¡C¥»¤å»EµJ¦bT2D¡A¥H¹ê¥Î©M§ó·sªºÆ[ÂI¡A°w¹ï¿}§¿¯fªº§PÂ_¡B¨­Å鬡°Ê/¹B°Êªº¯q³B¡B¹B°Ê³B¤è»P«ü¾É©M¹B°Ê®Éªºª`·N¨Æ¶µµ¥­±¦V¥[¥H»¡©ú¡C

¶L¡B¿}§¿¯fªº§PÂ_

¡@¡@¦å¿}­È¬O§_¥¿±`¥i¨Ì¾Ú¬ü°ê¿}§¿¯f¨ó·| (American Diabetes Association, 2019 ) ªº¼Ð·Ç¨Ó§PÂ_¡A¦pªG¿}¤Æ¦å¦â¯À (HbA1C) < 5.7%¡BªÅ¸¡¦å¿} < 100 mg/dl¡B¨â¤p®É¸²µå¿}§Ô¨ü«×´úÅç¦å¿}­È < 140 mg/dl©M¨S¦³°ª¦å¿}¯gª¬ (¦p଻Ħå¯g) ¥|­Ó¶µ¥Ø¬Ò¥¿±`¡A´N¨S¦³¿}§¿¯f¡F¦pªGHbA1C > 6.5%¡BªÅ¸¡¦å¿}¿@«× >126 mg/dl¡B¸²µå¿}§Ô¨ü«×´úÅç¨â¤p®É«á¦å¿} > 200 mg/dl©Î¦³°ª¦å¿}¯gª¬¥|­Ó¶µ¥Ø¤¤¡A¥ô¦ó¤@¶µ¶W¹LÁ{¬É­È´N¦³¿}§¿¯f¡C¦³Ãö¦å¿}¥¿±`¡B¿}§¿¯f«e´Á (prediabetes) ©M¿}§¿¯fªº§PÂ_¼Ð·Ç¦pªí1¡C

¡@¡@¿}¤Æ¦å¦â¯À (HbA1C) ¬O¦å¿}¹L¥h2¦Ü3­Ó¤ëªº¥­§¡¿@«× ¡A¸û¬°Ã­©w¬Oµû¦ô§_¦³¿}§¿¯fªº­«­n¤èªk¡C¸²µå¿}§Ô¨ü«×´úÅ窺¥Øªº¦bÀË´ú¿}§¿¯f¡B¯Ø®q¯À§Ü©Ê (resistance) ©Î¯ØÅ¦£]²Ó­Mªº¥\¯à¡A¦bÄá¨ú75§J¸²µå¿}«á2¤p®É¡A¦pªG¦å¿}¹L«×¤W¤É¡A´N¦³¸²¿}¿}§Ô¨ü©Ê»Ùê (impaired glucose tolerance)¡CªÅ¸¡¦å¿}¬O±`¥Î¥B²³æªº¤èªk¡A¦bªÅ¸¡¦Ü¤Ö¤K¤p®É«á¡A¦p¦å¿}¹L°ª¡A´N¦³ªÅ¸¡¦å¿}»Ùê (impaired fasting glucose)¡C§Æ±æ¦å¿}­Èºû«ù¦b²z·Qª¬ºA¡A¦p¦å¿}³B©ó¿}§¿¯f«e´Á¡A´N­n§Y®É±±¨î©ÎºÞ²z¡A¥H§KÂà¤Æ¬°¿}§¿¯f¡C

ªí1¡G¿}§¿¯f©M¿}§¿¯f«e´Áªº§PÂ_¼Ð·Ç
¦WºÙ/¯gª¬¥¿±`¿}§¿¯f«e´Á¿}§¿¯f
¿}¤Æ¦å¦â¯À (HbA1C)< 5.7%5.7-6.4%> 6.5%
ªÅ¸¡¦å¿}¿@«×< 100 mg/dl100-125 mg/dl>126 mg/dl
¨â¤p®É¦å¿}§Ô¨ü«×´úÅç¦å¿}¿@«×< 140 mg/dl140-199 mg/dl> 200 mg/dl
¨ä¥L¯S¼x ¦³°ª¦å¿}¯gª¬©Î¦MÀI (¦p଻Ħå¯g)¡AÀH¾÷¦å¿}­È¶W¹L> 200 mg/dl


°Ñ¡B³W«ß¨­Å鬡°Ê/¹B°Êªº¯q³B

¡@¡@¨­Å鬡°Ê¥]¬A¹B°Ê (¦p¦³®ñ¹B°Ê©Mªý¤O°V½mµ¥) ©M¤é±`¬¡°Ê (¦p¶éÃÀ©M±½¦aµ¥)¡A¥»¤å´£¨ìªº¡u¨­Å鬡°Ê¡v»P¡u¹B°Ê¡vÁö¦WºÙ¤£¦P¡A¦ý³£ÄÝ©ó¦Ù¦×¦¬ÁY·|²£¥Í¯à¶qªº°Ê§@¡A³q±`·|¥æ¤¬¨Ï¥Î¡C¹L¥h¬ã¨s±´°Q¨­Å鬡°Ê¹ïT2Dªº¼vÅT¡A¥D­n¥H¦³®ñ°V½m©Îªý¤O°V½m¬°¥D¡A¥»¤å²Î¾ã¬ÛÃö¤åÄm (¥]¬AACSM, 2022; Kanealey, et al., 2022; The Department of Health and Human Service, 2018; Colberg, et al., 2010; ¤è¶i¶©¡A2019)¡A¥Ñ³æ¦¸¹B°Ê©M³W«ß¹B°Ê¨â­Ó¼h­±¡A±Ô­z¨­Å鬡°Ê¹ïT2Dªº¯q³B¦p¤U¡G

¤@¡B³æ¦¸¹B°Êªº¯q³B

(¤@)§ïµ½¯Ø®q¯À±Ó·P«×¡G³æ¦¸¹B°Ê·|¼W¥[¯Ø®q¯À±Ó·P©Ê¡A©ó¹B°Ê«á«ùÄò2-72¤p®É¡A¦Ó¾É­P¦å¿}¤U­°¡A¼vÅTµ{«×»P¹B°Ê±j«×©M«ùÄò®É¶¡¦³Ãö (Colberg, et al., 2010; Kanealey, et al., 2022)¡C
(¤G)¥H¤£¦PºÞ¹DÄá¨ú¸²µå¿}¡G¦b¥ð®§®É¡A¦å¤¤¸²µå¿}¨Ì¿à¯Ø®q¯À§@¥Î¶i¤J°©Àf¦Ù¡A ¦ý¯Ø®q¯Àªý§Ü (»Ùê) ªºT2D±wªÌ¡A´NµLªk³z¹L³oºÞ¹D¿é°e¸²µå¿}¡C¦Ó¦b¹B°Ê®É¡A·|³z¹L¥t¤@­Ó (¤£»Ý¯Ø®q¯À) ³q¹D¨Ó¶Ç°e¸²µå¿}¡A¦Ó¤£¨ü¯Ø®q¯À§Ü©Ê©Î¬OT2Dªº¼vÅT (Colberg, et al., 2010; Kanealey, et al., 2022)¡C
(¤T)À\«á¹B°Ê´î§C¦å¿}¿@«×¡G¥ÎÀ\«á¡A¤£½×±q¨Æ¤°»ò¤è¦¡©Î±j«×ªº¹B°Ê¡A¦p®ø¯Ó¸û¦h¯à¶q´N·|´î§CÀ\«á¦å¿}¿@«×¡A¦Ó«ùÄò®É¶¡¸ûªø (¦p¹B°Ê¶W¹L45¤ÀÄÁ)¡A¥iÀò±oªº®Ä¯q·|¸û©úÅã©Î¤@­P (Kanealey, et al., 2022)¡C
(¥|)§ïµ½¦å¿}±±¨î¡G³æ¦¸¤¤µ¥±j«×¦³®ñ¹B°Ê (¦p¨«¸ô) ©óµu®É¶¡¤º·|§ïµ½¦å¿}±±¨î¡C¦p®ø¯Ó¯à¶q¬Û¦P¡A¦UºØ¹B°Ê¤è¦¡ (¥]¬A¦³®ñ¹B°Ê¡Bªý¤O¹B°Ê¡B·ì¦÷©Î¤Ó·¥®±µ¥) ¬Ò¥i§ïµ½¦å¿}±±¨î¡A¥B®ÄªG¬Ûªñ¡C
(¤­)´î§CªÅ¸¡¦å¿}¡G³æ¦¸ªý¤O°V½m¹ïT2D±wªÌªº¬ã¨s¸û¤Ö¡A¬ã¨s«ü¥Xªý¤O°V½m«á¦Ü¤Ö¤G¤Q¥|¤p®É¡AªÅ¸¡¦å¿}»ÙêªÌªºªÅ¸¡¦å¿}·|­°§C¡C
(¤»)¨ä¥L¡G³æ¦¸¹B°Ê¥i¥H§ïµ½¤ß±¡¡A¦pÓV¸ÑÀ£¤O©MµJ¼{¡Bªq³à¡C

¤G¡B³W«ß¨­Å鬡°Êªº¯q³B

(¤@)´î¤Ö¿}§¿¯fªº¿©±w­·ÀI
1.³W«ß¹B°Ê¥i¥H¹w¨¾©Î¿ð½wT2D«e´ÁÂàÅܬ°T2D (ACSM, 2022)¡C
2.³W«ß¨­Å鬡°Ê¥i¥H©úÅã´î¤Ö¿©±wT2D­·ÀI (The Department of Health and Human Service, 2018)¡C
3.¨C¶g±q¨Æ§C©ó150-300¤Àªº¤¤µ¥±j«×¦³®ñ¹B°Ê¡A¥i´î¤ÖT2D¿©±w²v¡A¦Ó¹B°Ê®É¶¡¶V¤[ (¦p¶W¹L150-300¤À)¡A¶V¯à­°§C¿©±w­·ÀI (The Department of Health and Human Service, 2018)¡C

(¤G)§ïµ½¯Ø®q¯À±Ó·P©Ê
1.³W«ß¦³®ñ¹B°Ê©Îªý¤O°V½m¬Ò¥i§ïµ½T2D¯Ø®q¯Àªº±Ó·P«×¡C
2.µu®É¶¡ (¦p¤C¤Ñ) ¦³®ñ°V½m¥i§ïµ½T2D¯Ø®q¯À±Ó·P«×¡C
3.ªý¤O°V½m¥i¥H§ïµ½¯Ø®q¯À±Ó·P«×¡A¦Ó°ª±j«×°V½mªº®ÄªG§ó¦n (Kanealey, et al., 2022)¡C

(¤T)§ïµ½¦å¿}±±¨î
1.³W«ß¨­Å鬡°Ê§ïµ½T2D¦å¿}§Ô¨ü«× (ACSM, 2022)¡C
2.³W«ß¦³®ñ¹B°Ê§ïµ½T2Dªº¦å¿}¿@«×¡A¥i¤U­° 0.5%¡V0.7% ¿}¤Æ¦å¦â¯À (Kanealey, et al., 2022)¡C
3.ªý¤O°V½m¥i§ïµ½¦å¿}±±¨î¡A¦Ó°ª±j«×°V½m§ïµ½ªº®ÄªG§ó¦n (Kanealey, et al., 2022)¡C
4.³W«ß¨­Å鬡°Ê¥i´î§CÀ\«á¦å¿}¿@«×¡C
5.³W«ß¨­Å鬡°Ê¥i´î¤Ö¨C¤Ñ°ª¦å¿}ªº®É¶¡¡C
6.µ²¦X¦³®ñ°V½m©Mªý¤O°V½mªº¦å¿}±±¨î®ÄªG¤ñ³æ¤@¹B°Ê°V½m¦n¡A¥i´î¤Ö§ó¦hªºHbA1C¡C

(¥|)´î»´Åé­«
1.Åé­«¹L­«©ÎªÎ­D¬OT2Dªº¿W¥ß¦MÀI¦]¤l¡A³W«ß¹B°Ê¥i´î¤ÖÅé­«¹L­«©MªÎ­D­·ÀI¡C
2.­n´î»´Åé­«¡A¨C¶g¦Ü¤Ö­n±q¨Æ150¤ÀÄÁ¤¤µ¥±j«×¹B°Ê¡A­nªø´Áºû«ù´î­«®ÄªG¡A»Ý­n±q¨Æ¨C¶g200-300¤ÀÄÁ¤¤µ¥±j«×¹B°Ê¡C
3.³W«ß¹B°Ê¥i¥H´î­«¨Ã¹w¨¾´î­««áªºÅé­«¦A«ì´_¡A¦Ó¹B°Êµ²¦X¶¼­¹ (¯à¶q­­¨î) ªº®ÄªG¸û¨Î¡C
4.´î­«¤â³N«e±q¨Æ¾A«×¨­Å鬡°Ê¡A¥i¯à·|§ïµ½¤â³Nµ²ªG¡A­Y¦b¤â³N«á¤S±q¨Æ¹B°Ê¡A·|²£¥Í§ó¦hªº¯q³B¡C

(¤­)´î¤Ö¯e¯f¿©±w²v
1.³W«ß¹B°Ê§ïµ½T2Dªº°·±dºÞ²z¡A¨Ã´î§C¿©±w¬ÛÃö¯e¯fªº­·ÀI (Kanealey, et al., 2022)¡C
2.¨C¶g±q¨Æ¤¤µ¥±j«×¹B°Ê150¤ÀÄÁ¡A©M´î¤Ö¯e¯f¿©±w²v¦³Ãö¡A¥]¬AT2D¤§¿©±w²v¡C
3.³W«ß¨­Å鬡°Ê¥i¥H´î¤ÖT2D±wªÌ©Ò¦³¯e¯f¦º¤`²v¡B¤ß¦åºÞ¯e¯f¦º¤`²v©M¤¤­·ªº­·ÀI¡C
4.¸û¦h¨­Å鬡°Ê¶q©M¸û¨ÎÅé¾A¯à¡A»P´î¤ÖT2D±wªÌ¾ãÅ馺¤`²v©Î¤ß¦åºÞ¯e¯f¦º¤`²v¦³¬ÛÃö¡C

(¤»)§ïµ½¤ß²z°·±d
1.³W«ß¹B°Ê¥i¥H§ïµ½T2D±wªÌ¤ß²z¯S½è¡A¦pÀ£¤O¡B¼~Æ{©MµJ¼{¡C
2.³W«ß¹B°Ê§ïµ½¥Í¬¡«~½è (ACSM, 2022)¡C
3.T2D±wªÌ¼W¥[¨­Å鬡°Ê¶q©MÅé¾A¯à¡A¥i´î§C¼~Æ{©M§ïµ½°·±d¦³Ãö ªº¥Í¬¡«~½è¡C

(¤C)¨ä¥L
1.³W«ß¹B°Ê (¦³®ñ¹B°Ê©Mªý¤O¹B°Ê) ¥i¥H§ïµ½¤ßªÍ¥\¯à¡B¦Ù¦×½è¶q©M¦Ù¤O»P¦Ù­@¤O¡C
2.´£¤É¯ØÅ¦£]²Ó­M¤Àªc¯Ø®q¯À¥\¯à¡C
3.§ïµ½¤ß¦åºÞ¯e¯f¦MÀI¦]¯À (The Department of Health and Human Service, 2018; ACSM, 2022)¡C
4.³W«ß¹B°Ê¥i¥H´£¤É¦åºÞ¥\¯à©M¸z¹Dµß¥\¯à (Kanealey, et al., 2022)¡C

¸v¡B¿}§¿¯f±wªÌªº¹B°Ê³B¤è»P«ü¾É

¡@¡@¹L¥hT2Dªº¹B°Ê°V½m¬ã¨s¡A±Ä¥Î³Ì¦hªº¤¶¤J¤è¦¡¬O¦³®ñ¹B°Ê©Mªý¤O°V½m¡C¦p¨S¦³¯e¯f¨Öµo¯g¡AT2D±wªÌ¥i±Ä¥Î¤@¯ë¦¨¦~¤Hªº¹B°Ê«ü¾É­ì«h¡A¥»¸`°Ñ¦ÒACSMªº¦@ÃÑ«ØÄ³¡A¤¶²Ð¨S¦³¨Öµo¯gT2D±wªÌ¦³®ñ¹B°Ê¡Bªý¤O°V½m¡B¦ù®i¾Þ©M¥­¿Å°V½mªº¹B°Ê³B¤è (Kanaley, et.al., 2022)¡A¨Ã¥Ñ¾i¦¨¹B°Ê²ßºD©M´î¤Ö¹B°Ê¶Ë®`ªº¨¤«×¥[¥H»¡©ú¡C

¤@¡B¦³®ñ¹B°Ê

¡@¡@¦³ÃöT2D¦¨¦~¤Hªº¦³®ñ¹B°Ê³B¤è¡A¥]¬A¹B°Ê¤è¦¡¡B±j«×¡BÀW²v¡B«ùÄò®É¶¡©Mº¥¶i­t²üµ¥¦]¯À¡AACSMªº«ØÄ³¤º®e¦pªí2¡C
(¤@)¹B°Ê¤è¦¡¡G ¿ï¾Ü©M±q¨Æ¦Û¤v¤è«K©M³ßÅwªº¦³®ñ¹B°Ê¡A¦p¨«¸ô¡BÃM¸}½ñ¨®©Î¦³®ñ»RÁе¥¡A¸û®e©ö¨É¨ü¹Lµ{©M¾i¦¨¹B°Ê²ßºD¡C
(¤G)¹B°Ê±j«×¡G¿ï¾Ü¾A¦Xªº¹B°Ê±j«×¡A¤£¥Î«j±j±q¨Æ¿E¯P¹B°Ê¡A±q¨Æ§C¤¤±j«×¬¡°Ê´N¥iÀò±o«Ü¤j¯q³B¡C¥i¥Î¹B°Ê¦Ûı¶qªí©Î³Ì¤j¤ß¸õ«O¯d­È (HRR )¨Ó¦ô­p¹B°Ê±j«×¡A¤@¯ë¦Ó¨¥¡A»´ÃPªº¬¡°Ê¬°§C±j«×¡A¨«¸ô¬°¤¤±j«×¡A¦Ó¶]¨B¬°¿E¯P±j«×¡C§C±j«×¬¡°Ê®É¡A¤ß¸õ©Î©I§lµy·L¼W¥[¡A¥i¥HÁ¿¸Ü©M°Ûºq¡A¦Ó±q¨Æ¤¤µ¥±j«×¬¡°Ê®É¡A¤ß¸õ©Î©I§l¦³ÂI«æ«P¡AÁÙ¥i¥HÁ¿¸Ü¡A¦ý¤£©ö°Ûºq¡A¦Ó¿E¯P¹B°Ê®É¡A¤ß¸õ©M©I§l«æ«P¡A¤£©öÁ¿¸Ü©Îºq°Û¡C
(¤T)¹B°ÊÀW²v¡G¨C¶g3¦Ü7¤Ñ¡A¥ð®§®É¶¡¤£­n¶W¹L¨â¤Ñ¡C¶}©l¹B°Ê®É¡A¿ï¾Ü¾A¦XªºÀW²v¡A¥u­n¤Ñ¼Æ¤ñ¥H«e¦h¤@ÂI¡A´N·|¦³°V½m®ÄªG¡A³vº¥¾AÀ³«á¡A¦A¼W¥[¹B°ÊÀW²v¡Aª½¨ì¨C¤Ñ¹B°Ê¡A¨C¤Ñ¯à¦b©T©w®É¶¡¹B°Ê¡A¦å¿}¸û©ö±±¨î¡A¤]¸ûí©w¡C
(¥|)«ùÄò®É¶¡¡G ¨C¦¸¹B°Ê®É¶¡¾A·í§Y¥i¡A¤ñ¥­±`¦h¤@ÂI´N·|¶i¨B¡A¥Ø¼Ð¬O¨C¦¸¹B°Ê¦Ü¤Ö30¤ÀÄÁ¡A¤£½×¬O«ùÄò©Î¦h¦¸²Ö¿n¡CACSM«ØÄ³¨C¶g¦Ü¤Ö±q¨Æ150-300¤À¤¤µ¥±j«×¦³®ñ¹B°Ê¡A©Î¬O75-150¤ÀÄÁ¿E¯P¹B°Ê¡A©Î¬O¤¤µ¥»P¿E¯P±j«×¥æ¤¬·f°t¡A¤@¯ë¦Ó¨¥¡A¿E¯P¹B°Ê¤@¤ÀÄÁµ¥©ó¤¤µ¥±j«×¹B°Ê¤G¤ÀÄÁ¡C¦p­nÀò±o§ó¦h¯q³B¡A¨C¶g­n±q¨Æ¶W¹L300¤ÀÄÁ¤¤µ¥±j«×¦³®ñ¹B°Ê¡C
(¤­)º¥¶i­t²ü¡G­n¦Ò¶q­Ó§O®t²§¡AºCºCªº¼W¥[­t²ü¡A¦p¼W¥[«ùÄò®É¶¡¡B±j«×©ÎÀW²v¡C¶}©l¹B°Ê®É¦pµLªk¨C¶g¨«¸ô150¤À¡A ´N¦b¦Û¤vªº°ò¦ÂI¤W¡A¦b¥i¥H§Ô¨üªºª¬ªp¤U¡AºCºC¼W¥[­t²ü¡A¹F¨ì«ØÄ³ªº¹B°Ê¶q¡C­ì«h¤W¡Aº¥¶i­t²ü¥ý¼W¥[«ùÄò®É¶¡¡Aª½¨ì¨C¦¸¥i³sÄò¹B°Ê30¤À«á¡A¦A¼W¥[±j«×¡A³Ì«á¼W¥[¹B°ÊÀW²v¡A¨C¤@¦¸¼W¥[¤@­Ó¶µ¥Ø§Y¥i (¦p¼W¥[«ùÄò®É¶¡¡B±j«×©ÎÀW²v)¡C¹B°Ê¬O¤@½ú¤lªº¨Æ±¡¡AºCºC¼W¥[­t²ü¡A´N·|¹F¨ì¹w©w¥Ø¼Ð¡A¦¬³Î¯Ñ¯Ð¦¨ªG¡C

¤G¡Bªý¤O°V½m

¡@¡@¦³ÃöACSM T2D¦¨¦~¤Hªý¤O°V½mªº¹B°Ê³B¤è¡A¥]¬A¹B°Ê¤è¦¡¡B±j«×¡BÀW²v¡B«ùÄò®É¶¡©Mº¥¶i­t²üµ¥¦]¯À¡A«ØÄ³¤º®e¦pªí2¡C
(¤@)¹B°Ê¤è¦¡¡G¿ï¾Ü¤è«K®e©ö¹ê¬Iªº°V½m¤è¦¡¡A ¦p§Q¥Î²¾°Ê¾¹§÷ (¦p°×¹a¡B¼u¤O±a) ©Î¦Û¨­Åé­«¡A¦b®a¸Ì©Î¿ì¤½³õ©ÒÀH®É¬Ò¥i°V½mªº¤è¦¡¡C·íµM¡A¯à°÷¥H­«°V¾÷±ñ°V½m³Ì¦n¡A¥i¤è«K´x±±°V½m­t²ü¡Cªý¤O°V½m¤À¬°µ¥±i¡Bµ¥ªø©Mµ¥³t°V½m¡A¦]¨ü­­©ó­«°V»ö¾¹¡A¸û±`¨Ï¥Îªº°V½m¤è¦¡¬°µ¥±i©Mµ¥ªø°V½m¡A¦Óµ¥±i°V½m³Ì¬°´¶¹M¡C¥H¦Û¤vÅé­«§@¬°°V½m¤è¦¡¡A¦p±q´È¤l¤ÏÂЯ¸¥ß»P§¤¤U¡A¥i°V½m¤j»L¦Ù¸s¡A³oºØ¤è¦¡®e©ö¹ê¬I¡A¬O¥Ø«e¥@¬ÉÅé¾A¯àªºÁÍ¶Õ (Thompson, 2022)¡C
(¤G)¹B°Ê±j«×¡G¦p¯à´ú¥X¨C­Ó¦Ù¦×ªº³Ì¤j¦Ù¤O¡A«h¤¤µ¥±j«×©M¿E¯P±j«×¥i¤À§O¥H50%¡V69% ©Î 70%¡V85% ªº³Ì¤j¦Ù¤O (1RM) ªí¥Ü¡C¹B°Ê±j«×¥ç¥i¥H¹B°Ê¦Ûı¶qªíªí¥Ü¡A ¦b 0 (¨S¦³·Pı) ¨ì 10 («D±`«D±`±j) ¤§¶¡ªº¦Ûı¶qªí¡A¤¤µ¥±j«×¬° 5-6¡A·Pı±j¡A¦Ó¿E¯P±j«×¬°7-8¡A·Pı«D±`±j¡C¶}©l¹B°Ê®É¿ï¾Ü¾A¦X¦Û¤vªº±j«×¡A ı±o¦³ÂI­t²ü§Y¥i¡A±j«×©Î­t²ü¤£­n¤Ó±j¡C ÁöµM°ª±j«×ªý¤O°V½mªº¦å¿}±±¨î®ÄªG¤ñ§Cµ¥±j«×¦n¡A¦ý»Ý­n´`§Çº¥¶i¡A¥Ñ¸û§Cªº±j«×¶}©l¡A¦A³vº¥¼W¥[±j«×¡C
(¤T)¹B°ÊÀW²v¡G¨C¶g°V½m 2¡V3 ¤Ñ¡C¤Z¨Æ°_ÀYÃø¡Aªý¤O°V½m¤]¬O¤@¼Ë¡A¶}©l¹B°Ê®É¡A¿ï¾Ü¾A·íªºÀW²v¡AÅý¨­¤ß¦³¨¬°÷®É¶¡½Õ¾ã¡A¦p¥H«e¨S¦³ªý¤O°V½m¸gÅç¡A¥i±q¨C¶g¤@¤Ñ¶}©l¡A¾AÀ³«á¦A¼W¥[¨ì¨C¶g 2¤Ñ¡A¬Æ¦Ü 3¤Ñ¡C
(¥|)«ùÄò®É¶¡¡G«ùÄò®É¶¡¨Ì°V½m°Ê§@¼Æ¥Ø¡B¤ÏÂЦ¸¼Æ¡B¦^¦X¼Æ»P¥ð®§®É¶¡¦Ó©w¡A¶}©l°V½m®É¡A«ùÄò®É¶¡­n¤Ö¤@ÂI¡A¥]¬A°V½m°Ê§@¡B¹B°Ê±j«×©M¦^¦X¼Æ³£­n¤Ö¤@ÂI¡A¾AÀ³«á¦AºCºC¼W¥[¡C ¶}©l°V½m®É¡A°V½m°Ê§@¤­¤»­Ó§Y¥i¡A±j½Õ«º¶Õªº¥¿½T©Ê¡A¦Ó¤£¬O­t²ü¡A°µ¤@¦^¦X´N¥i¥H¤F¡AµM«á¦A¼W¥[¦^¦X¼Æ¡C
(¤­)º¥¶i­t²ü¡GºCºC¼W¥[­t²ü¡A¤~¯à²£¥Íªý¤O°V½m®ÄªG¡C¨C­Ó°Ê§@¿ï¾Ü¾A«×ªº­t²ü¡A¬ù¥i±q¨Æ10-15¤ÏÂЦ¸¼Æ¡A¨ì¥i¥H¤ÏÂаV½m15¦¸¡A¬ù¸g¹L¨â¦¸°V½m«á¡A¦A¼W¥[ªý¤O©Î­t²ü¡A«ùÄò¤ÏÂаV½m«á¡A¦A¼W¥[¦^¦X¼Æ¡A¥Ñ¤@¦^¦X¨ì¤T­Ó¦^¦X¡A³Ì«á¦A¼W¥[ÀW²v¡Cº¥¶i­t²ü¥i¥H¥ÑÁ`°V½m¶q¨ÓÆ[¹î¡A¤@­Ó°Ê§@ªºÁ`°V½m¶q¬°­t²ü (ªý¤O) ­¼¥H¤ÏÂЦ¸¼Æ»P¦^¦X¼Æ¡A¦p¥H10¤½¤ç°×¹a°µªÐÃö¸`©}Á|10¦¸¡A°µ¤@¦^¦X¡A«hÁ`°V½m¶q¬°100¤½¤ç¡A­nº¥¶i­t²ü¡A¥i¥H¼W¥[¤ÏÂЦ¸¼Æ¡Bªý¤O©Î¦^¦X¼Æ¡A°V½m¹Lµ{¤¤¡A¥u¼W¥[¤@­Ó¶µ¥Ø§Y¥i (¦p¤ÏÂЦ¸¼Æ)¡A¤£¥Î¦P®É¼W¥[¨â­Ó¶µ¥Ø¥H¤W (¦p¼W¥[¤ÏÂЦ¸¼Æ©Mªý¤O)¡C

ªí2¡F²Ä¤GÃþ«¬¿}§¿¯f±wªÌ¦³®ñ¹B°Ê©Mªý¤O°V½mªº¹B°Ê³B¤è«ØÄ³ªí
ºØÃþ\¶µ¥Ø¹B°Ê¤è¦¡¹B°Ê±j«×ÀW²v«ùÄò®É¶¡º¥¶i­t²ü
¦³®ñ¹B°Ê¨«¸ô¡B¶]¨B¡BÃM¸}½ñ¨®¡B´åªa¡B¸õ»R©M¶¡·²°V½mµ¥¡C¤¤µ¥±j«×¡G40%¡V59% ³Ì¤j¤ß¸õ«O¯d­È (HRR ), RPE 11¡V12¡F
¿E¯P±j«×¡G 60%¡V89%³Ì½ñ¤ß¸õ«O¯d­È (HRR ) , RPE 14¡V17
¨C¶g 3¡V7¤Ñ¡A¤£¹B°Ê®É¶¡¤£­n¶W¹L¨â¤Ñ¡C ³Ì¤Ö¨C¶g150¡V300 ¤ÀÄÁ¤¤µ¥±j«×©Î 75¡V150 ¤ÀÄÁ¿E¯P±j«×¹B°Ê¡A©Î¬O¤¤µ¥±j«×»P¿E¯P±j«×¹B°Êªº²Õ¦X¡C¨Ì¾Ú¨C­Ó¤Hªº¶}©lÅé¾A¯à¡B¦~ÄÖ¡B°·±dª¬ªp©M­Ó¤H¥Ø¼Ð¡AºCºCªº¼W¥[¹B°Ê®É¶¡¡B±j«×©ÎÀW²v¡C
ªý¤O°V½m²¾°Ê¹B°Ê¾¹§÷ (¦p°×¹a)¡Bªý¤O¾¹§÷¡B¼u¤O±a©Î¦Û¤vÅé­«¡A°µ¤K¦Ü¤QºØ°V½m¤j¦Ù¦×¸s°Ê§@¡C¤¤µ¥±j«×¡G50%¡V69% of 1RM¡A
©Î¿E¯P±j«×¡G 70%¡V85% 1RM
¨C¶g 2¡V3 ¤Ñ¡A¦ý¤£­n³sÄò°V½m¨â¤Ñ¡C¨C­Ó°Ê§@°V½m 10¡V15 ¦¸ (1¦^¦X)¡A°µ 1¡V3 ¦^¦X¡C ¦b¥i¥H§Ô¨üªºª¬ªp¤U¡A¶}©l¼W¥[ªý¤O¡A±µµÛ¼W¥[¦^¦X¼Æ¡AµM«á¼W¥[°V½mÀW²v¡C
µù¡G%HRR= % (³Ì¤j¤ß¸õ²v - ¦wÀR¤ß¸õ²v ) + ¦wÀR¤ß¸õ²v¡CRPE=¹B°Ê¦Ûı¶qªí¡C

¤T¡B¦ù®i¾Þ°V½m

¡@¡@°£¦³®ñ¹B°Ê©Mªý¤O°V½m¥~¡A¤]­n±q¨Æ¦ù®i¾Þ¥H§ïµ½¬X³n«×¡A¦ù®i¾Þªº¹B°Ê³B¤è¦p¤U¡G
(¤@)¹B°Ê¤è¦¡¡G¿ï¾Ü¤è«Kªº¦ù®i¾Þ¡A¦p°ÊºA©ÎÀRºA¦ù®i¡B¥»Åé·Pı¯«¸g¦Ù¦×«P¶i³N (PNF)¡B·ì¦÷¡B¤Ó·¥®±¡B¥­¿Å¹B°Êµ¥¡C
(¤G)°V½mÀW²v¡G¨C¶g°V½m2¤Ñ¥H¤W¡C
(¤T)¹B°Ê±j«×¡G¦ù®i¨ì¦³ÂIºò¡A¦ý¤£¯kµhªºµ{«×¡C
(¥|)«ùÄò®É¶¡¡G¦ù®i¥þ¨­­«­nÃö¸`¡A¨C­Ó°Ê§@¦ù®i10-30¬í¡A¤ÏÂÐ2-4¦¸¡C
(¤­)º¥¶i­t²ü¡G¦b¥i¥H§Ô¨ü©M¤£¯kµhªºª¬ªp¤U¡A¼W¥[¦ù®i½d³ò¡C ¦ù®i¾Þ­n¿Ä¤J°V½m¤º®e¡A¦ý¤£¯à´À¥N¦³®ñ©Îªý¤O°V½m¡C

¥|¡B¥­¿Å°V½m

¡@¡@¥­¿Å¤£¨ÎªºT2D±wªÌ»Ý­n±q¨Æ¥­¿Å°V½m¡A¥H´î¤Ö¶^­Ë¾÷²v¡A¨ä¹B°Ê³B¤è¦p¤U¡G
(¤@)¹B°Ê¤è¦¡¡G¿ï¾Ü¦b®a¸Ì¤è«K¹ê¬Iªº¥­¿Å¹B°Ê¡A¦p§Q¥Î°×¹a©MÅé­«±q¨Æªý¤O°V½m¡A¯S§O¬O¥[±j¤UªÏ©M®Ö¤ß¦Ù¸sªº°V½m¡A¦¹¥~¡A¥i±q¨Æ¤Ó·¥®±¡B·ì¦÷µ¥¨ä¥L¦Û¤v³ßÅwªº¨­Å鬡°Ê¡C
(¤G)¹B°ÊÀW²v¡G¨C¶g¦Ü¤Ö 2 ¤Ñ¡C
(¤T) º¥¶i­t²ü¡G¦b¥i¥H§Ô¨ü¦Ó¤£·|¶^­Ëªº­ì«h¤U¡A³vº¥¼W¥[¥­¿Å°V½mªº§xÃø«×¡A¦p´î¤Ö¨â¸}¤ä«ù­±¡B¼W¥[¨­Åé²¾°Ê½d³ò©Î³¬¤W²´·úµ¥¡A¦b¨C­Ó°Ê§@¥i¥Hºû«ù¬ù 30 ¬í«á¡A³vº¥¼W¥[°V½m°Ê§@ªº§xÃø«× (©Î±j«×)¡C¥­¿Å°V½m­nª`·N¦w¥þ¡A®ÇÃ䦳¤ä¼µª«©Î¦³¹Ù¦ñ«OÅ@¡A¥i´î¤Ö¶^­Ëªº­·ÀI¡C
(¥|)¦³Ãö¥­¿Å°V½mªº±j«×©M«ùÄò®É¶¡¡A¥Ø«e¨S¦³©ú½Tªº«ØÄ³¡A¥i¦Ò¶q¨C­Ó¤Hªº°·±d»PÅé¯àª¬ªp¡A­Ó§O³]­p¾A¦X¹B°Ê±j«× (©Î­t²ü) »P«ùÄò®É¶¡¡C

¤­¡B¬ÛÃö¨­Å鬡°Êªº«ØÄ³

(¤@)¼x¸ß°·±d·ÓÅ@¤H­û¡G±q¨Æ¹B°Ê«e¡A­n½Ð±Ð±M·~°·±d·ÓÅ@¤H­û (§tÂå®v©M¦X®æÅé¾A¯à±Ð½m)¡A°µ¹B°Ê«eªº¦w¥þµû¦ô¡A¨Ã´£¨Ñ¹B°Ê«ü¾É©M«ØÄ³¡C
(¤G)´î¤Ö¤[§¤®É¶¡¡G¤[§¤©MT2D»P¾ãÅ馺¤`²v¦³Ãö¡A¸g±`¥H§C±j«×¬¡°Ê (¦p¨«¸ô©Î¦ù®i¾Þ) ¤¤Â_¤[§¤¡A·|¼W¥[¯Ø®q¯À±Ó·P«×©M´î§C¦å¿}¿@«×¡CÀR¤î¤@¬q®É¶¡ (¦p¤@¤p®É) «á¡A°_¨Ó¬¡°Ê¤@¤U¡A§Y¨Ïµu®É¶¡ (¦p3-5¤À)¡A´N·|´î§CÀ\«á¦å¿}©M¯Ø®q¯À¿@«×¡A¯S§O¬O¦³¯Ø®q¯À§Ü©Ê©ÎÅé­«¹L­«©ÎªÎ­DªÌ¡C
(¤T)¦³¹B°Ê¤ñ¨S¦³¹B°Ê¦n¡G¶}©l¹B°Ê®É¡A¥i¯àµLªk¹F¨ìACSMªº«ØÄ³¶q¡A¨C¶g¨«¸ô150¤À¡A¦ý­n¦b¥i¥H§Ô¨üª¬ªp¤U¡AºÉ¶q¼W¥[¨­Å鬡°Ê¶q¡A«O«ù¡u¦³¬¡°Ê¤ñ¨S¦³¹B°Ê¦n¡v²z©À¡C
(¥|)±M·~¤H­ûªº¨ó§U¡GT2D±wªÌ±q¨Æ¹B°Ê®É¡A¦p¦³±M·~¤H­û«ü¾É©MºÊ·þ¡A¸û®e©ö«ùÄò¹B°Ê©M±±¨î¦å¿} (Kanaley, et.al., 2022)¡C¶}©l±q¨Æ¦³®ñ©Mªý¤O°V½m®É¡A¦³±M·~±Ð½m¨ó§U©M«ü¾É¡A¤£¦ý¾Ç²ß¹B°Êª¾¯à¡A¤]¥i¦b¸û¦w¥þ©M¤ä«ùªºª¬ªp¤U¡AÀò±o¸û¦hªº°·±d¯q³B¡C
(¤­)±±¨îÅé­«¡G­n§ïµ½¿}¤Æ¦å¦â¯À (A1C)¡B¦å¯×ªÕ©M¦åÀ£¡A¬ù»Ý´î­«5%¥H¤W (Kanaley, et.al., 2022)¡A¥u¾a¹B°Ê´î­«¡A¨C¤Ñªº¹B°Ê®É¶¡­nªø¡A ¬ù60¤À (Colberg, et al., 2010)¡C­n´î¤Ö¤ºÅ¦ (¸¡³¡) ¯×ªÕ¡A«h´X¥G­n¨C¤Ñ¹B°Ê¡A ¨C¤Ñ¬ù­n®ø¯Ó¼ö¶q500¤j¥d¡A ©Ò¥H¡Aµ²¦X¶¼­¹©M¹B°Ê¬O¸û¦³®Äªº´î­«¤è¦¡ (Kanaley, et.al., 2022)¡C
(¤»)¥¥°ü¹B°Ê¡G¥¥°ü¤£ºÞ¦³¨S¦³¿}§¿¯f¡A«ØÄ³¨C¬P´Á³Ì¦n¨C¤Ñ¹B°Ê (¦Ü¤Ö¨C¶g¤­¤Ñ)¡A¨C¤Ñ±q¨Æ¦Ü¤Ö20¡V30 ¤À¤¤µ¥±j«×ªºªº¹B°Ê (¦p¨«¸ô) (Kanaley, et.al., 2022)¡C
(¤C)¤â³N«e«á¹B°Ê¡G¦³¨Ç¿}§¿¯f±wªÌ·|Âǵۤâ³N¨Ó´î»´Åé­«¡A¥H§ïµ½°·±d©M¦å¿}±±¨î¡C¦b¤â³N«e«á±q¨Æ¾A«×ªº¨­Å鬡°Ê¡A¥i¯à·|§ïµ½¤â³Nµ²ªG¡A¥B²£¥Í§ó¦h«ì´_®Ä¯q (Kanaley, et.al., 2022)¡A«ØÄ³ÂǤâ³N´î­«ªÌ­n±q¨Æ³W«ß¹B°Ê¡C
(¤K)¹B°Ê¥Í¬¡¤Æ¡G¡u¹B°Ê¥Í¬¡¤Æ¡vªº²z©À¡A¬OÀH®ÉÀH¦a§Q¥Î¾÷·|¹B°Ê¡A¦b®a¸Ì¡B¿ì¤½«Ç¡B¾Ç®Õ¡B¤W¤U¯Z®É¶¡©Î¶g¥½®É¶¡¡Bµ¥¤½¨®©Î¬Ý¹qµø®É¡A¦³¾÷·|´N±q¨Æ¨­Å鬡°Ê¡A´N®e©ö¹F¨ì¹w´Á¥Ø¼Ð¡A¦p¡u¤é¦æ¸U¨B¡v¡C
(¤E)±q¨Æ¦³®ñ°V½m©Mªý¤O°V½m¡G¦³®ñ¹B°Ê©Mªý¤O°V½m¬Ò¥i§ïµ½¦å¿}±±¨î¡A¦Ó¨âºØ¹B°Ê°V½m®ÄªG¤ñ³æ¤@°V½m¦n¡A«ØÄ³¦P¨Æ±q¬O¨âºØ¹B°Ê¡C
(¤Q)©w´Á°·±dÀˬd¡G °·±dÀˬd¥i¤F¸Ñ¦å¿}±±¨îª¬ªp¡A¦p¦³¿}§¿¯f«e´Á©Î¿}§¿¯f¯gª¬¡A­n¿n·¥±Ä¨ú¦æ°Ê¡A¤Î¦­¾i¦¨°·±d¥Í¬¡¤è¦¡¡A¥]¬A³W«ß¹B°Ê¡A¥H¹w¨¾¯e¯f´c¤Æ©Î§ïµ½¦å¿}±±¨î¡C

¥î¡B¹B°Ê®ÉÀ³ª`·N¨Æ¶µ

¡@¡@¨Ì¾Ú¹B°Ê³B¤èªº«ØÄ³¡AT2D±wªÌ±q¨Æ¹B°Ê¹Lµ{­n¯àºû«ù¦å¿}í©w¡AÁ×§K°ª¦å¿}©Î§C¦å¿}²{¶H¡A¤]»Ý¤p¤ß¹w¨¾ªÏÅé¨ü¶Ë©Î¹B°Ê·N¥~¡C¬°¦w¥þ©M¦³®Äªº±q¨Æ¹B°Ê¡A¥»¸`¤¶²Ð¹B°Ê«eªº¦w¥þ»PÂåÀøµû¦ô¡B¹B°Ê®Éª`·N¨Æ¶µ©M¦³¨Öµo¯gªÌ¹B°Êª`·N¨Æ¶µ¡C

¤@¡B¹B°Ê«eªº¦w¥þ»PÂåÀøµû¦ô

¡@¡@T2D±wªÌ¹B°Ê«eªº¦w¥þµû¦ô»P¹B°ÊÀ£¤O´úÅç«ØÄ³¦p¤U¡G
(¤@)±q¨Æ¹B°Ê«e¡A­n¼x¸ßÂå®v©Î±M·~°·±d·ÓÅ@¤H­ûªº¦P·N¡C¹B°Ê«eªº¦w¥þµû¦ô (¦p¨Ï¥ÎPAR-Q°Ý¨÷)¡A¥i°Ñ¦Ò2015¦~ACSMªºµû¦ô¤è¦¡»P¬ÛÃö¸ê®Æ (¤è¶i¶©¡A2021)¡C§Y¨Ï¨S¦³¹B°Ê²ßºD¡AT2D±wªÌÀò±o°·±d·ÓÅ@¤H­û¦P·N«á¡A¥i¥H¶}©l±q¨Æ§C¦Ü¤¤±j«×ªº¬¡°Ê¡A¹³»´·L¬¡°Ê©Î¨«¸ô¡A³vº¥¾AÀ³«á¡A¦b¥i¥H§Ô¨üªºª¬ªp¤U¡A¨Ì¾ÚACSMªº«ØÄ³³vº¥¼W¥[­t²ü¡C
(¤G)¦pªG¤U¦Cª¬ªp©Î¯gª¬¤§¤@ªÌ¡A«ØÄ³¦b¹B°Ê«e¥h¿Ô¸ßÂå®v¡A»Ý­n®É¦A°µ¹B°ÊÀ£¤O´úÅç (exercise stress testing)¡A¥D­n¥]¬A¡G
1.¦pªG¿©±wT2D±wªÌ¦~ÄÖ¶W¹L¥|¤Q·³¡C
2.¯e¯f¥v¶W¹L¤Q¦~¡C
3.¦³¤U¦C¯gª¬¡G¤ß¦åºÞ¯e¯f¡B«aª¬°Ê¯ß¯e¯f¡A©PÃä°Ê¯ß¯e¯f¡Bµøºô½¤¼W¥Í¡B¦Û¥D¯«¸g¯fÅÜ¡B±ß´ÁµÇŦ°IºÜªºµÇ¯f¡C

¡@¡@³o¬O¸û¬°«O¦uÂÔ·Vªº«ØÄ³¡A¦]¬°T2D±wªÌ¬O§_»Ý­n±q¨Æ¹B°ÊÀ£¤O´úÅç¡A¥Ø«e¬ã¨sµ²ªG¤£¤@­P¡C¬ã¨s«ü¥X¦³©Î¨S¦³±q¨Æ¹B°ÊÀ£¤O´úÅç¡A¨â²Õ°Ñ»PªÌ¹B°Ê®Éªº¤ß¦åºÞ¯e¯f·N¥~¾÷²v¬Ò«D±`¤p¡A¤]¨S¦³ÅãµÛ®t²§¡A¥B¹B°ÊÀ£¤O´úÅç¨S¦³´î§C¤ß¦åºÞ¯e¯f·N¥~¨Æ¥ó¡C¦¹¥~¡A±q¨Æªý¤O°V½m«e¡AT2D±wªÌ¬O§_»Ý­n±q¨Æ¹B°ÊÀ£¤O´úÅç¡A¥Ø«e¨S¦³¬ã¨sÃҹꥦªº»Ý­n©Ê©M¯q³B (Kanaley, et al., 2022)¡C

¡@¡@¹ê¬I¹B°ÊÀ£¤O´úÅç­n¦Ò¶q±M·~ÂåÅ@¤H­û¡B»ö¾¹³]³Æ¡B¸g¶O­t¾áµ¥±ø¥ó¡A¦]¦¹¡A¦b¦³¥²­n©M±ø¥ó°t¦X®É¤~¥i¯à¹ê¬I¡A§_«h¹L«×ÂåÀøÀË´ú©ÎÂश¥i¯à¤£¹ê»Ú¡A¤]·|³y¦¨¹B°Ê°Ñ»Pªº»Ùê¡C©Ò¥H¡A¦pªGµLªk¹ê¬I¹B°ÊÀ£¤O´úÅç¡A¥i±Ä¨ú²Ä¤@¶µACSM¹B°Ê«e¦w¥þµû¦ôªº«ØÄ³¡C

¤G¡B¹B°Ê®Éª`·N¨Æ¶µ

¡@¡@µL¨Öµo¯gªÌ¥­®É¹B°Ê®É¡A¬°¹w¨¾§C¦å¿}©M¹B°Ê¶Ë®`µ¥²{¶H¡A­nª`·N¤U¦C¨Æ¶µ ¡G
(¤@)±±¨î¦å¿}¿@«×¡G¹B°Ê«e«á­n¦Û§ÚºÊ´ú¦å¿}¡A¤F¸Ñ¹B°Ê±j«×©M®É¶¡¹ï¦å¿}ªº¼vÅT¡A¤è«K¥­®É¶¼­¹©Î¯Ø®q¯À¾¯¶qªº½Õ¾ã¡A¹B°Ê«e¦å¿}­nºû«ù¦b100-250 mg/dl ¤§¶¡¡C
(¤G)¦å¿}¤Ó°ª®É¤£­n¹B°Ê¡G¹B°Ê«e¦p¦å¿}¶W¹L300 mg/dl¡A©Î¬O¦å¿}¶W¹L250mg/dl¥B¦å²G©Î§¿²G¤¤¥X²{à¬Åé(ketone)¡A³£¼È®É¤£­n¹B°Ê¡C
(¤T)§C¦å¿}®ÉÄá¨ú¿}Ãþ¡G¹B°Ê«e¦p¦å¿}§C©ó80-100 mg/dl¡A­nÄá¨úºÒ¤ô¤Æ¦Xª« (¦pªG¥Ä©Î¿}ªG) ©Î´î¤Ö¯Ø®q¯Àª`®g¶q¡A¤@¯ë½Õ¾ã¶¼­¹¸û¤è«K¡C
(¥|)¹w¨¾§C¦å¿}²{¶H¡G¹B°Ê·|¼W¥[¯Ø®q¯À±Ó·P«×¡A±wªÌ¹B°Ê«e¦p¨Ï¥Î¯Ø®q¯À¡A­n´î¤Ö¾¯¶q¡A¦b¹B°Ê¤¤©Î¹B°Ê«á­n¸É¥R¿}Ãþ¡A¥H¹w¨¾§C¦å¿}²{¶H¡C
(¤­)¸É¥R¤ô¤À¡G¦b¹B°Ê«e¤¤«á¡A­n¸É¥R¨¬°÷¤ô¤À¡A¤]¤£­n¦b¤@¤Ñ³Ì¼ö©Î¤Ó¶§ª½±µ·Ó®g®É¶¡¹B°Ê¡A¥HÁ×§K¨­Åé¹L¼ö©Î²æ¤ô¡C
(¤»)½Õ¾ã¯Ø®q¯À¡G¸g¹L¤@¬q®É¶¡¹B°Ê°V½m«á¡A¯Ø®q¯Àªº±Ó·P«×·|§ïµ½¡A­n½Ð±ÐÂå®v¬O§_»Ý­n´î§C¯Ø®q¯Àªº¾¯¶q¡A¥H´î¤Ö§C¦å¿}²{¶H¡C
(¤C)¹w¨¾¨ü¶Ë¡G¹B°Ê®É­nª`·N½Ã¥Í©M¹w¨¾¨ü¶Ë¡A¬ïµÛ¾A·íªºªA¸Ë©M¾cÄû¡A¥H´î¤ÖªÏÅé©Î¸}³¡°_ªw©Î¨ü¶Ë¡C
(¤K)¼g¹B°Ê¤é°O¡G¬ö¿ý¹B°Ê©MÃĪ«ªº¬ÛÃö¸ê®Æ¡A¥]¬A¹B°ÊºØÃþ¡B±j«×¡B«ùÄò®É¶¡©Î¶ZÂ÷¡AÃĪ«¦WºÙ¡B¾¯¶q©M¨Ï¥Î®É¶¡¡A©M¿}Ãþ¸É¥RªººØÃþ©M¥÷¶q¡A¥i¥H¤F¸Ñ¹B°Ê¡BÃĪ«©M¶¼­¹¹ï¦å¿}ªº¼vÅT©Î¥æ¤¬§@¥Î¡A¤è«K¦å¿}½Õ±±¡C

¤T¡B¦³¨Öµo¯gªÌ¹B°Êª`·N¨Æ¶µ

¡@¡@¤j³¡¤ÀT2D±wªÌ¥i¦w¥þ¦³®Ä±q¨Æ¤¤§C±j«×¹B°Ê¡A¦ÓÀò±o©úÅã®Ä¯q (Kanaley, et al., 2022)¡C¦³¯e¯f¨Öµo¯g¡A¹B°Ê«e­n¼x¸ß©M½Ð±ÐÂå®v©Î±M·~°·±d·ÓÅ@¤H­û¡A¹B°Ê®É»Ý¿í¦u¤@¨Ç«ü¾É­ì«h©Mª`·N¨Æ¶µ¡C¤@¯ë¥Á²³ªº¹B°Ê³B¤è¡A¤]¾A¦X¦³¨Öµo¯gªº±wªÌ¡A¦ý­n¦Ò¶q­Ó§O®t²§¡A¨Ì¾Ú¨C­Ó¤HªºÅé¯à¡B°·±d¡B¯gª¬©M¹B°Êª¬ªp¡A¦b¹B°Ê±j«×¡B«ùÄò®É¶¡¡BÀW²v©Îº¥¶i­t²üµ¥¶µ¥Ø°µ¾A«×½Õ¾ã¡CT2D¬ÛÃö¨Öµo¯g«Ü¦h¡A¥]¬A¦Û¥D¯«¸g¯fÅÜ¡B©PÃ䯫¸g¯fÅÜ¡Bµøºô½¤¯fÅÜ¡BµÇŦ¯fÅÜ©M°ª¦åÀ£¡A¥»¸`°Ñ¦ÒACSMªº¦@Ãѳø§i (Kanaley, et.al., 2022)¡A±N¹B°Êª`·N¨Æ¶µ©M«ØÄ³¾ã²z©óªí 3¡C

ªí 3¡G¿}§¿¯f¨Öµo¯g¹B°Ê®Éªºª`·N¨Æ¶µ»P«ØÄ³
¨Öµo¯gª`·N¨Æ¶µ»P«ØÄ³
¦Û¥D¯«¸g¯fÅÜ¡­¦Û¥D¯«¸g¯fÅܩΥ¢½Õ·|¼vÅT¤ßŦ¡B·Å«×±±¨î©M¦åÀ£½Õ¾ãµ¥¥\¯à¡A¤p¤ß¹B°Ê®É¥i¯à¼W¥[§C¦å¿}¡B±Æ¦½²§±`¡B¤£¥¿±`¦åÀ£¤ÏÀ³©MÅé·Å½Õ¾ã»Ùêµ¥²{¶H¡C±wªÌ·|¼W¥[¦wÀR¤ß¸õ²v¡A¹B°Ê®Éªº¤ß¸õ²v¤ÏÀ³·|¸û§C©Î¿ð¶w¡C

¡­¨Ï¥Î¹B°Ê¦Ûı¶qªí (RPE) §@¬°¹B°Ê±j«×¨Ì¾Ú¡C

¡­±Ä¨úµ¦²¤¹w¨¾²æ¤ô¡BÅé·Å¹L°ª©MÅé·Å¹L§Cªº²{¶H¡C
©PÃ䯫¸g¯fÅÜ#©PÃ䯫¸g¯fÅÜ·|³y¦¨³\¦h¯gª¬¡A¦p¼W¥[¯kµh»PIJı±Ó·P©Ê¡B¦Ù¦×µê®z©ÎµäÁY©MªÏÅé·Pı³Â¤ì©Îµo¼ö²{¶H¡C¦Ó³W«ß¹B°Ê·|±a¨Ó³\¦h¯q³B¡A¥]¬A§ïµ½¦Ù¤O¡B¦å²G´`Àô©MºÎ¯v«~½è¡A¤]´î¤Ö¯kµh¡B©âµ¬¡B¦åÀ£µ¥¯gª¬¡C

#¶}©l¹B°Ê®É­n¦Ò¶q¦Û¤vªº°·±d»P¯gª¬¡A¿ï¾Ü¾A·íªº¹B°Ê¤è¦¡¡A¦p±q¨ÆµL¤ä¼µÅé­«ªº¹B°Ê¡A¦pÃM¸}½ñ¨®¡B§¤¦b´È¤lªº¬¡°Ê¡C¤£­n°Ñ»P·|³y¦¨»L³¡³Ð¶Ëªº¨­Å鬡°Ê¡A¹³ªø®É¶¡ª¦¤s¡B¶]¨B©Î¨«¦b¤£¥­¸ô­±¡C

#¨C¤ÑÀˬd¸}³¡¬O§_¦³¨ü¶Ë©M¬õ¸~²{¶H¡A¤p¤ß¿ï¾Ü¦X¾AµÎªAªº¾c¤l©MÄû¤l¡A¨Ã«O«ù¸}³¡°®Àê¡C

#¶}©l¹B°Ê®É¡A¹B°Ê¶q­n¤Ö¡A®É¶¡­nµu©M±j«×­n§C¡A¤£­n¤Ó«j±j¡A¾AÀ³«á¦AºCºC¼W¥[­t²ü¡C

#Á×§K±q¨Æ¹L«×©Î¶W¥X¥­¿Å¯à¤Oªº¬¡°Ê¡C¨C¦¸¹B°Ê«á­n°µ¦ù®i¡A¥H¼W¥[¬X³n«×©M´î¤Ö¦Ù¦×ºòÁ^»P¤£¾A¡C
µøºô½¤¯fÅÜ¡­¦]¤£Ã­©wªº¦åºÞ¼W¥Í©MÄY­«ªºµøºô½¤¨Öµo¯g¡A­nÁ×§K¿E¯P¡B°ª±j«×ªº¹B°Ê¡C¼W´Þ©Êµøºô½¤¯fÅܬO¦]ªø´Áµø ºô ½¤ ¯Ê ®ñ ¾É ­P ·L ¦å ºÞ ¼W ¥Í©Ò¾É­Pªº¯gª¬¡C

¡­©M²´¬ìÂå®v°Q½×¹B°Êªºª`·N¨Æ¶µ¡C­nÁ×§K³¬®ðªº¬¡°Ê¡A¦pÁ|­«©Îµ¥ªø¦¬ÁY¡C Á×§K­n§CÀYªº¹B°Ê (¦p·ì¦÷©ÎÅé¾Þ) ©Î¬O¾_°ÊÀY³¡ªº°Ê§@¡C

¡­§Q¥Î¹B°Ê¦Ûı¶qªíRPE¨Ó¨M©w©ÎºÊ±±¹B°Ê±j«×¡A¦b6-20ªºµ¥¯Å¶qªí¡Aºû«ù¦b10 to 12¤§¶¡¡C

¡­¦pªG¦³¤U¦C¯gª¬´N¤£­n¹B°Ê¡A¥]¬A¤£Ã­©w©Î¨SªvÀøªº¼W¥Í©Êµøºô½¤¯fÅÜ¡B³Ìªñ¥þµøºô½¤¥ú¾®©TªvÀø©Î²´·ú¤â³N¶}¤M¡C
µÇŦ¯fÅÜ#¿}§¿¯fµÇ¯f¬O·L¦åºÞ¨Öµo¯g«Ü´¶¹Mªº¯gª¬¡A·|¼W¥[¿}§¿¯f±wªÌ¦º¤`²v¡C

#Á×§K±q¨Æ¤Þ°_¦åÀ£¹L«×¼W°ªªº¹B°Ê¡A¦pÁ|­«¡B°ª±j«×¦³®ñ¹B°Ê¡A©Î¬O­n³¬®ðªº¬¡°Ê¡C °ª¦åÀ£¬O«Ü´¶¹Mªº¯gª¬¡A¦åÀ£¨S¦³±±¨î·|¥[³tµÇ¥\¯àªº°h¤Æ¡A¦Ó§C±j«×ªº¦³®ñ¹B°Ê¬OºÞ²z¦åÀ£©M¯h³Ò«Ü­«­nªº¤èªk¡C¦pªG¹q¸Ñ½è±±¨î±o¦n¡A¦b¦å²G³zªR®É±q¨Æ§C¦Ü¤¤±j«×ªº¹B°Ê¬O¥i¯àªº¡C
°ª¦åÀ£#Á×§KÁ|­«©M³¬®ð¬¡°Ê¡C±q¨Æ§C¦Ü¤¤±j«×ªº¦³®ñ¹B°Ê¡A¹³¨«¸ô©MÃM¸}½ñ¨®¡C

#¨Ì¾Ú°ª¦åÀ£ªº¹B°Ê«ü¾É­ì«h¨Ó¬¡°Ê¡A¦p¨S¦³´ú¶q³Ì¤j¤ß¸õ²v¡A«h¨Ï¥Î¹B°Ê¦Ûı¶qªí§@¬°¹B°Ê±j«×¡A«ØÄ³¦b6-20¶qªí¡A¥H10 to 12§@¬°­t²ü¡C

¡@¡@°ò¥»¤W¡A¨Öµo¯g±wªÌ©ó¹B°Ê®É¡A°£°Ñ¦Ò¤W¸`µL¨Öµo¯g±wªÌªºª`·N¨Æ¶µ¥~¡A ¥ç­nÃö¤ß¤U¦C¨Æ¶µ¡G
(¤@)¦p¦³¤£Ã­©w¯gª¬¡B³Ìªñ¶}¤M©Î¨­Å餣¾Aµ¥ª¬ªp¡A­n¼È®É°±¤î¹B°Ê¡C
(¤G)¦w¥þ²Ä¤@¡A±q¨Æ¥i¥H§Ô¨üªº§C¦Ü¤¤±j«×¬¡°Ê¡AÁ×§K¿E¯P©Î¼²À»©Êªº¹B°Ê¡A¥H§K³y¦¨¨­Å餣¾A¡B¯kµh©Î¨ü¶Ë¡C
(¤T)¥H¡u¤£¯kµh¡v¬°­ì«h¡A¨­Å鬡°Ê®É­n¶ÉÅ¥¨­ÅéÁn­µ¡A¤£­n¿E¯P¨ì¨­Å餣¾A©Î¯kµh¡A­n¨É¨ü¹B°Ê¹Lµ{¡C¦p¦³¯kµh²{¶H¡A­n°±¤î¹B°Ê©Î´î§C±j«×¡C
(¥|)¾i¦¨°·±d¥Í¬¡¤è¦¡¡A°£³W«ß¹B°Ê¥~¡A­n¾i¦¨¨}¦nªº¶¼­¹©M¥Í¬¡²ßºD¡AÁ×§K­t­±ªº¥Í¬¡¤è¦¡¡A¦p©â·Ï¡B³¤°s¡BÃĪ«ÀݥΩμõ©]¡C
(¤­)±Ä¨ú¾ãÅé°·±d (wellness) µ¦²¤¡A°£­ÝÅUÃĪ«¡B¶¼­¹©M¹B°Ê¥~¡A¤]­n¦Ò¶q¾ãÅé°·±dªº¦]¯À¡A¦p¯à´£¤É¾ãÅé°·±d(©ÎºÙ¥þ¤H°·±d)ªº¥Í²z¡B¤ß²z¡BªÀ·|¡BÀô¹Ò»PÆF©Ê°·±d¡A¹ï©ó¯e¯fªvÀø©M°·±d«P¶i§ó¦³§U¯q (¤è¶i¶©¡A2022)¡C
(¤»)´£¤É¦Û§Ú®Ä¯à¡A¹B°Ê¦Û§Ú®Ä¯à¬O³\¦h¦æ¬°§ïÅܪk²z½×©Î¼Ò¦¡ªº¦@¦P¯à¤O©Îµ¦²¤¡A ­n¹B°Ê¥Í¬¡¤Æ¡A´N­n´£¤É¦Û§Ú®Ä¯à¡A¦³«H¤ßÀH®ÉÀH¦a¦Û§Ú¹B°Ê (¤è¶i¶©¡A2019)¡C
(¤C)¿Ä¤J¥¿©À¡G©ó¥Í¬¡¤¤©M¨­Å鬡°Ê¤¤¿Ä¤J¥¿©À¡A¤£¦ý¥i¥H¦w©w¨­¤ß¡BÓV¸ÑÀ£¤O¡A¤]¥i¼W¥[¨­Å鬡°Ê¶q¡A¹ï°·±d«P¶i¦³¥¿­±ªº§U¯q (¤è¶i¶©¡A2021)¡C
(¤K) ¥H¦Û¤v¬°®v¡G­n±±¨î¯e¯f©M§ïµ½°·±d¡A°£°·±d·ÓÅ@¤H­û¥~¡A³Ì­«­nªº¬O¦Û¤v¡A§Ú­Ì³ÌÁA¸Ñ¦Û¤vªºª¬ªp©M»Ý­n¡A¤]²M·¡­þ¨Ç¦æ¬°¡B²ßºD©Î©ÀÀY¹ï°·±d³Ì¦³À°§U¡A­n·í¦Û¤vªº¡u¨}®v¡v¡A¬Û«H¦Û¤v¨ã¨¬ÀøÂ¡ªº¼ç¯à©M´¼¼z¡A¥i¤Þ¾É¦Û¤v©¹°·±d©M¥¿½Tªº¤è¦V«e¶i¡C

³°¡Bµ²»y

¡@¡@¿}§¿¯f¬ù§xÂZ¤Q¤À¤§¤@ªº¤H¤f¡A¨ä¤¤¬ù¤E¦¨¬OT2D¡A¦å¿}¦p¨S¦³§´·í±±¨î¡A´N®e©ö²£¥Í¨Öµo¯g¡A¦Ó¼vÅT¥Í¬¡«~½è©M°·±dª¬ªp¡C¥Ø«eªvÀø©MºÞ²z¿}§¿¯fªº¤T­Ó¥D­n¤è¦¡¬OÃĪ«¡B¶¼­¹©M¹B°Ê¡A¾¨ºÞ³\¦h¬ã¨s«ü¥X³W«ß¨­Å鬡°Ê¥i¥H±a¨Ó³\¦h¯q³B¡A¦ý¤j³¡¤À±wªÌÁÙ¬O¹B°Ê¤£¨¬¡Aºû«ùÀRºA¥Í¬¡¤è¦¡¡C

¡@¡@¥»¤åºî°ê¤º¥~¬ÛÃö¤åÄm¡A¤À¨ÉT2D»P¨­Å鬡°Êªº¬ÛÃöª¾¯à¡A¥]¬A³W«ß¹B°Êªº¯q³B¡B¹B°Ê³B¤è©Mª`·N¨Æ¶µ¡A§Æ±æ¹ñ·s©M¹ê¥Îªº¸ê°T¡AÅýT2D±wªÌ¤F¸Ñ³W«ß¹B°Êªº­«­n¡A¥B¥i¨Ì´`¹B°Ê³B¤èªº«ü¾É­ì«h©Mª`·N¨Æ¶µ¡A¦³«H¤ßªº±Ä¨ú¨ãÅ馿°Ê¡A¼W¥[¨­Å鬡°Ê¶q©M¾i¦¨¹B°Ê²ßºD¡F§ó´Á¬ß¯f±w¯à±Ä¨ú¦h¤¸µ¦²¤¡A¯u¥¿¦³®Äªº¹w¨¾©M±±¨î¿}§¿¯f¡A­°§C¹ïÃÄ«~¤§¨Ì¿à¡A¦ÓÅé·|¡u¹B°Ê¬O¨}ÃÄ¡vªº¬ü¦n¡C

°Ñ¦Ò¤åÄm

¤è¶i¶© (2022)¡C°ªÄ֪̪º¹B°Ê»P¥þ¤H°·±d¡C²Ä¤Gª©¡CµØ³£¡C

¤è¶i¶© (2019)¡C¹B°Ê³B¤è¡C²Ä¤Gª©¡CµØ³£¡C

¤è¶i¶© (2021) ¡C±N¥¿©À¿Ä¤J¨­Å鬡°Ê¡C¹B°Ê¥Í²z¶g°T¡A476¡Chttp://www.epsport.net/epsport/week/show.asp?repno=476

¤è¶i¶© (2016)¡C ¹B°Ê«eªº°·±dµû¦ô¡X2015¦~ACSMªº·s«ØÄ³¡C¹B°Ê¥Í²z¶g°T¡A338 ¡Chttp://www.epsport.net/epsport/week/show.asp?repno=338

American College of Sports Medicine (2022). ACSM's Guidelines for Exercise testing and Prescription, 11th edition, Philadelphia, PA: Lippincott Williams & Wilkins, 441-460.

American Diabetes Association (2019). Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care, 42(Supplement 1), S13-S28.

Colberg, S., Sigal, R., Fernhall, B., Regensteiner, J., Blissmer, B., Rubin, R., Chasan-Taber, L., Albright, A., & Braun, B. (2010). Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint Position Statement Executive Summary. Diabetes care, 33, 2692-2696.

Kanakey, J. A., Colberg, S. R., Corcoran, M. H., Malin, S. K., Rodriguez, N. R., Crespo, C. J., Kirwan, J. P., & Zierath, J. R. (2022). Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine. Medicine & Science in Sports & Exercise, 54(2), 353-368.

Thompson, W. R. (2022). FACSM Worldwide Survey of Fitness Trends for 2022. ACSM's Health & Fitness Journal, 26(1), 11-20.

U.S. Department of Health and Human Service (2018). Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: U.S. Department of Health and Human Service.

¡@¦@¦³ 0 ¦^À³


¡@¡@¦^¤W­¶ ¡@¡@µoªí¦^À³
 B ʥͲz Ǻ
 B ʥͲz Ǻ     Ǥƶ] B V m
 B ʥͲz Ǻ    x W   a V m A ȥ  x
 B ʥͲz Ǻ      Z w   P V m B
    (PFQ) [ c
 B ʥͲz Ǻ    C ֦~    פ  R
 B ʥͲz Ǻ   YouTube W D
¤ßªÍ¾A¯à°V½mªº²z½×»P¹ê»Ú

¥xÆW¹B°Ê¥Í²zº[Åé¯à¾Ç·|

 j M     ҾǥZ

¹B°Ê¥Í²z¾Çºô¯¸
¹B°Ê¬ì¾Ç±Ð¨|¬ã¨s«Ç